Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $11.3900 (-3.72%) ($10.7300 - $12.2800) on Thu. Aug. 8, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.04% (three month average) | RSI | 29 | Latest Price | $11.3900(-3.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -1.8% a day on average for past five trading days. | Weekly Trend | FOLD declines -4.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(60%) XBI(56%) IWO(55%) IWM(52%) IWC(50%) | Factors Impacting FOLD price | FOLD will decline at least -1.52% in a week (0% probabilities). VIXM(-33%) VXX(-19%) TLT(-15%) IFRA(-10%) TIP(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.52% (StdDev 3.04%) | Hourly BBV | 0 () | Intraday Trend | -7.2% | | | |
|
1 - 5 Day Possible Target | $4.64(-59.26%) | Resistance Level | $12.4 | 5 Day Moving Average | $11.67(-2.4%) | 10 Day Moving Average | $12.13(-6.1%) | 20 Day Moving Average | $12.4(-8.15%) | To recent high | -14% | To recent low | 3.9% | Market Cap | $2.941b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |